Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 63 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Thursday
During Thursday's trading, 50 companies set new 52-week lows.
Inventiva Announces The Screening Of The First Patient In LEGEND, A Phase IIa Combination Trial With Lanifibranor And Empagliflozin In Patients With NASH And T2D
The Phase IIa Proof-of-Concept study is designed to assess the safety and efficacy of lanifibranor in combination with the SGLT2 inhibitor empagliflozin for the treatment of patients with non-cirrhotic non-alcoholic
Inventiva Raises €50M Debt Financing To Fund Its Lead Program In NASH Patients
Inventiva (NASDAQ:IVA) has signed a €50 million bullet credit facility agreement with the European Investment Bank. The company plans to use…
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
40 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Advent Technologies Holdings, Inc. (NASDAQ: ADN) shares jumped 77.7% to $3.5950. Advent Technologies and Hyundai Motor Company entered into technology assessment, sales and development agreement.
21 Stocks Moving in Wednesday’s Pre-Market Session
Gainers
Dakota Gold (NYSE: DC) shares rose 97.1% to $13.60 in pre-market trading. The company’s stock was uplisted to NYSE American on Tuesday.
FDA Gives Green Signal To Inventiva’s Mid-Stage Lanifibranor Study In NASH Patients
The FDA has completed a safety review of Inventiva SA's (NASDAQ: IVA) IND application and
Earnings Scheduled For March 7, 2022
Companies Reporting Before The Bell
• Niu Technologies (NASDAQ:NIU) is expected to report quarterly earnings at $0.21 per share on revenue of $144.02 million.